FIELD: pharmaceutical industry. SUBSTANCE: peroral antibechic pharmaceutical composition containing 0.5 to 2 standard doses of antibechic agent affecting central nervous system or its pharmaceutically acceptable salt and benzidamine in quantity equal to 1/200 to 2 weight doses of antibechic agent or equivalent quantity of pharmaceutically acceptable addition salt of benzidamine with acid. Composition is available in the form of pastilles, sugar candies, chewing tablets, or chewing gums. Antibechic agents are selected from group including codeine, dextromethorphan, dihydrocodeine, dimemorphan, noscapine, levopropoxyphon, napsilate, carbetapentane, caramiphen, chlophedianol, diphenidramin, glaucin, benzonatate, hydrocodone, hydromorphone and their pharmaceutical acceptable salts. EFFECT: reduced (due to added benzidamine) time before response of antibechic agent to peripheral stimulus of cough. 7 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BENZIDAMINE APPLICATION METHOD FOR TREATING PATHOLOGIC STATES INDUCED BY FUNCTIONAL METABOLISM DISORDERS | 1994 |
|
RU2160102C2 |
| PROCESS FOR PREPARING 2-BENZYL-3-(3-DIMETHYLAMINO-PROPYLTHIO)-2H-INDASOLE | 0 |
|
SU1042614A3 |
| PROCESS FOR PREPARING 1-BENZYL-3-HYDROXYMETHYLINDAZOLE ETHERS OF PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | 1991 |
|
RU2044729C1 |
| ANTITUSSIVE | 2009 |
|
RU2427388C2 |
| MEDICAL COMBINATION WITH THEOBROMINE AND USING IT IN TREATMENT | 2010 |
|
RU2519086C2 |
| DRUG COMBINATION WITH THEOBROMINE AND USE THEREOF IN TREATMENT | 2010 |
|
RU2587329C2 |
| LIQUID COMPOSITIONS OF PHENYLEPHRINE WITH INCREASED STABILITY | 2007 |
|
RU2468787C2 |
| ORALLY ADMINISTRATED LIQUID COMPOSITIONS COMPRISING GUAIFENESIN AND POLYOXYALKYLENE BLOCK-COPOLYMERS | 2002 |
|
RU2281087C2 |
| IBUPROFEN-CONTAINING ORAL PHARMACEUTICAL FORMULATION | 2019 |
|
RU2820239C2 |
| COMPOSITIONS CONTAINING NATURAL HONEY AND COMPOSITIONS PREPARATION METHOD | 2008 |
|
RU2465784C2 |
